Annual Retained Earnings
-$175.57 M
-$22.94 M-15.03%
December 31, 2023
Summary
- As of February 12, 2025, MTNB annual retained earnings is -$175.57 million, with the most recent change of -$22.94 million (-15.03%) on December 31, 2023.
- During the last 3 years, MTNB annual retained earnings has fallen by -$68.07 million (-63.31%).
- MTNB annual retained earnings is now -4483.31% below its all-time high of -$3.83 million, reached on December 31, 2013.
Performance
MTNB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$191.39 M
-$4.28 M-2.28%
September 30, 2024
Summary
- As of February 12, 2025, MTNB quarterly retained earnings is -$191.39 million, with the most recent change of -$4.28 million (-2.28%) on September 30, 2024.
- Over the past year, MTNB quarterly retained earnings has dropped by -$21.13 million (-12.41%).
- MTNB quarterly retained earnings is now -4896.24% below its all-time high of -$3.83 million, reached on December 31, 2013.
Performance
MTNB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
MTNB Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.0% | -12.4% |
| 3 y3 years | -63.3% | -12.4% |
| 5 y5 years | -166.2% | -12.4% |
MTNB Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.4% | at low | -45.4% | at low |
| 5 y | 5-year | -108.1% | at low | -126.8% | at low |
| alltime | all time | -4483.3% | at low | -4896.2% | at low |
Matinas BioPharma Holdings Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$191.39 M(+2.3%) |
| Jun 2024 | - | -$187.12 M(+3.2%) |
| Mar 2024 | - | -$181.40 M(+3.3%) |
| Dec 2023 | -$175.57 M(+15.0%) | -$175.57 M(+3.1%) |
| Sep 2023 | - | -$170.26 M(+3.7%) |
| Jun 2023 | - | -$164.20 M(+3.8%) |
| Mar 2023 | - | -$158.14 M(+3.6%) |
| Dec 2022 | -$152.63 M(+16.0%) | -$152.63 M(+2.4%) |
| Sep 2022 | - | -$149.00 M(+3.8%) |
| Jun 2022 | - | -$143.54 M(+4.3%) |
| Mar 2022 | - | -$137.61 M(+4.5%) |
| Dec 2021 | -$131.63 M(+22.4%) | -$131.63 M(+5.4%) |
| Sep 2021 | - | -$124.93 M(+5.8%) |
| Jun 2021 | - | -$118.10 M(+5.0%) |
| Mar 2021 | - | -$112.46 M(+4.6%) |
| Dec 2020 | -$107.51 M(+27.4%) | -$107.51 M(+6.3%) |
| Sep 2020 | - | -$101.17 M(+5.7%) |
| Jun 2020 | - | -$95.72 M(+7.0%) |
| Mar 2020 | - | -$89.42 M(+6.0%) |
| Dec 2019 | -$84.38 M | -$84.38 M(+7.1%) |
| Sep 2019 | - | -$78.80 M(+6.8%) |
| Jun 2019 | - | -$73.81 M(+5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -$70.00 M(+6.1%) |
| Dec 2018 | -$65.94 M(+28.6%) | -$65.94 M(+5.8%) |
| Sep 2018 | - | -$62.32 M(+6.0%) |
| Jun 2018 | - | -$58.80 M(+6.2%) |
| Mar 2018 | - | -$55.38 M(+8.0%) |
| Dec 2017 | -$51.27 M(+45.8%) | -$51.27 M(+7.6%) |
| Sep 2017 | - | -$47.65 M(+9.2%) |
| Jun 2017 | - | -$43.64 M(+10.0%) |
| Mar 2017 | - | -$39.68 M(+12.8%) |
| Dec 2016 | -$35.18 M(+51.7%) | -$35.18 M(+5.7%) |
| Sep 2016 | - | -$33.29 M(+23.0%) |
| Jun 2016 | - | -$27.06 M(+6.4%) |
| Mar 2016 | - | -$25.43 M(+9.7%) |
| Dec 2015 | -$23.19 M(+65.0%) | -$23.19 M(+9.5%) |
| Sep 2015 | - | -$21.18 M(+11.3%) |
| Jun 2015 | - | -$19.03 M(+14.5%) |
| Mar 2015 | - | -$16.62 M(+18.3%) |
| Dec 2014 | -$14.05 M(+266.8%) | -$14.05 M(+27.7%) |
| Sep 2014 | - | -$11.01 M(+31.1%) |
| Jun 2014 | - | -$8.40 M(+40.6%) |
| Mar 2014 | - | -$5.97 M(+55.8%) |
| Dec 2013 | -$3.83 M | -$3.83 M |
FAQ
- What is Matinas BioPharma Holdings annual retained earnings?
- What is the all time high annual retained earnings for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual retained earnings year-on-year change?
- What is Matinas BioPharma Holdings quarterly retained earnings?
- What is the all time high quarterly retained earnings for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly retained earnings year-on-year change?
What is Matinas BioPharma Holdings annual retained earnings?
The current annual retained earnings of MTNB is -$175.57 M
What is the all time high annual retained earnings for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual retained earnings is -$3.83 M
What is Matinas BioPharma Holdings annual retained earnings year-on-year change?
Over the past year, MTNB annual retained earnings has changed by -$22.94 M (-15.03%)
What is Matinas BioPharma Holdings quarterly retained earnings?
The current quarterly retained earnings of MTNB is -$191.39 M
What is the all time high quarterly retained earnings for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly retained earnings is -$3.83 M
What is Matinas BioPharma Holdings quarterly retained earnings year-on-year change?
Over the past year, MTNB quarterly retained earnings has changed by -$21.13 M (-12.41%)